‌

US Patent 9243058 BCMA antigen binding proteins

Patent 9243058 was granted and assigned to Amgen on January, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jason Charles O'Neill0

Gunasekaran Kannan0

Jiangchun Xu0

Mark Edward Tometsko0

Michelle Blake0

Richard J. Armitage0

William C. Fanslow, III0

Date of Patent

January 26, 2016

0

Patent Application Number

140982750

Date Filed

December 5, 2013

0

Patent Citations Received

US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules

0

US Patent 11884720 Antibody constructs for MSLN and CD3

0

US Patent 11912776 Chimeric antigen receptors targeting B-cell maturation antigen

0

0

US Patent 11987633 Cross-species-specific single domain bispecific single chain antibody

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9243058 BCMA antigen binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.